BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6297 related articles for article (PubMed ID: 3132176)

  • 1. Potency, selectivity and cell cycle dependence of catechols in human tumour cells in vitro.
    Kable EP; Parsons PG
    Biochem Pharmacol; 1988 May; 37(9):1711-5. PubMed ID: 3132176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.
    Kable EP; Parsons PG
    Cancer Chemother Pharmacol; 1989; 23(1):1-7. PubMed ID: 2909284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro.
    Yamada I; Seki S; Matsubara O; Ito S; Suzuki S; Kasuga T
    J Invest Dermatol; 1987 May; 88(5):538-40. PubMed ID: 3572026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of dopa toxicity in human tumour cells.
    Parsons PG
    Biochem Pharmacol; 1985 May; 34(10):1801-7. PubMed ID: 3924049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo depigmentation by hydroxybenzene derivatives.
    Menter JM; Etemadi AA; Chapman W; Hollins TD; Willis I
    Melanoma Res; 1993 Dec; 3(6):443-9. PubMed ID: 8161883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of the substituted catechols dihydroxyphenylalanine methyl ester and trihydroxyphenylalanine by lactoperoxidase and its compounds.
    Metodiewa D; Reszka K; Dunford HB
    Arch Biochem Biophys; 1989 Nov; 274(2):601-8. PubMed ID: 2552928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of antitumoral activity of catechols in culture.
    Picardo M; Passi S; Nazzaro-Porro M; Breathnach A; Zompetta C; Faggioni A; Riley P
    Biochem Pharmacol; 1987 Feb; 36(4):417-25. PubMed ID: 3103624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.
    Kern DH; Shoemaker RH; Hildebrand-Zanki SU; Driscoll JS
    Cancer Res; 1988 Sep; 48(18):5178-82. PubMed ID: 3136917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.
    Parsons PG; Morrison LE
    Cancer Res; 1982 Sep; 42(9):3783-8. PubMed ID: 6809313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity of (chloro-)catechols and (chloro-)catechol-copper combinations in Escherichia coli corresponds to their membrane toxicity in vitro.
    Schweigert N; Hunziker RW; Escher BI; Eggen RI
    Environ Toxicol Chem; 2001 Feb; 20(2):239-47. PubMed ID: 11351422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency and selective toxicity of tetra(hydroxyphenyl)- and tetrakis(dihydroxyphenyl)porphyrins in human melanoma cells, with and without exposure to red light.
    James DA; Arnold DP; Parsons PG
    Photochem Photobiol; 1994 Apr; 59(4):441-7. PubMed ID: 8022886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of toxicity of 5-S-cysteinyldopa to tumour cells. Hydrogen peroxide as a mediator of cytotoxicity.
    Ito S; Inoue S; Fujita K
    Biochem Pharmacol; 1983 Jul; 32(13):2079-81. PubMed ID: 6409113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
    Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
    Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human melanoma cells sensitive to deoxyadenosine and deoxyinosine.
    Parsons PG; Hayward IP
    Biochem Pharmacol; 1986 Feb; 35(4):655-60. PubMed ID: 3004507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure toxicity relationships for catechols in isolated rat hepatocytes.
    Moridani MY; Siraki A; Chevaldina T; Scobie H; O'Brien PJ
    Chem Biol Interact; 2004 Apr; 147(3):297-307. PubMed ID: 15135085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of cytotoxicity of catechols and a naphthalenediol in PC12-AC cells: the connection between extracellular autoxidation and molecular electronic structure.
    Chichirau A; Flueraru M; Chepelev LL; Wright JS; Willmore WG; Durst T; Hussain HH; Charron M
    Free Radic Biol Med; 2005 Feb; 38(3):344-55. PubMed ID: 15629863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen peroxide as an inducer of elevated tyrosinase level in melanoma cells.
    Karg E; Odh G; Wittbjer A; Rosengren E; Rorsman H
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):209S-213S. PubMed ID: 8433009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition.
    Zafar KS; Siegel D; Ross D
    Mol Pharmacol; 2006 Sep; 70(3):1079-86. PubMed ID: 16790533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 315.